Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 217-060-0 | CAS number: 1732-10-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin irritation: not irritant to skin (OECD 439, GLP, K, rel.1)
Eye irritation/damage: no classification required for eye irritation or serious eye damage (OECD 492, GLP, K, rel. 1)
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 16 August 2017 - 20 November 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- Study performed according to OECD test guideline No. 439 and in compliance with GLP.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- Adopted 28 July 2015
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
- Version / remarks:
- 23 July 2009
- Deviations:
- no
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- French GLP Compliance Programme for chemical products (inspected on 30-31 January 2017 / signed on 27 April 2017)
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Justification for test system used:
- Following the REACH bottom-up strategy, the EPISKIN™ Reconstructed Human Epidermis Model method was used to assess skin irritation as recommended in the OECD test guideline No. 439.
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: SkinEthic RHE® model
- Tissue batch number(s): 17-RHE-088
- Production date: Not reported
- Shipping date: Not specified
- Delivery date: 29 August 2017
- Expiry date: 04 September 2017
- Date of initiation of testing: 23 August 2017
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: room temperature
- Temperature of post-treatment incubation (if applicable): 37 °C
REMOVAL OF TEST MATERIAL AND CONTROLS
- Volume and number of washing steps: 25 x 1 mL of DPBS (Dutscher - Batch No. 9130617)
- Observable damage in the tissue due to washing: The rinsed tissues were checked for any coloration and noted to be whitish, comparable to negative control tissues.
- Modifications to validated SOP: None reported
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 1.0 mg/mL
- Incubation time: 3 hours
- Spectrophotometer: ELx800 absorbance microplate reader (controlled every year and calibrated if necessary) supplied by BioTek and the validated software Gen5 ELISA V1.05.11 supplied by BioTek
- Wavelength: 570 nm
- Filter: Not applicable
- Filter bandwidth: Not applicable
- Linear OD range of spectrophotometer: No data reported
FUNCTIONAL MODEL CONDITIONS WITH REFERENCE TO HISTORICAL DATA
- Viability: OD570= 1.4, CV= 4.3% (specification: OD > 0.7)
- Barrier function: ET50 (Exposure time inducing 50% viability using Triton X-100 1%)= 4.3h (specification: 4.0h =< ET50 =< 10.0h)
- Morphology: well differenciated epidermis consisting of basal, spinous, granular layers and a stratum corneum
- Contamination: : absence of bacteria, fungus and mycoplasma
- Reproducibility: not reported
CONTROL TISSUES USED IN CASE OF MTT DIRECT INTERFERENCE
- There is no direct interaction between the test item and MTT.
- No need to add non-specific coloration control since the test item has no coloration potential.
NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION: 1
PREDICTION MODEL / DECISION CRITERIA
- The test substance is considered to be irritant to skin if the tissue viability after 42 minutes of exposure and 42 hours of post-treatment incubation is ≤ 50%.
- The test substance is considered to be non-irritant to skin if the viability after 42 minutes of exposure and 42 hours of post-treatment incubation is > 50%. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 16 μL of the test item was then applied to the epidermal surface.
- Concentration (if solution): not applicable
VEHICLE
not applicable
NEGATIVE CONTROL
- Amount(s) applied (volume or weight): 16 μL of DPBS
- Concentration (if solution): undiluted
POSITIVE CONTROL
- Amount(s) applied (volume or weight): 16 μL of SDS
- Concentration (if solution): 5% w/v aqueous solution - Duration of treatment / exposure:
- Triplicate tissues were treated with the test item for an exposure period of 42 minutes at room temperature.
- Duration of post-treatment incubation (if applicable):
- At the end of the exposure period, tissues were rinsed and incubated at 37 °C, 5% CO2 in air for 41 hours in fresh medium.
- Number of replicates:
- 3 living tissues for test item, negative and positive controls
- Irritation / corrosion parameter:
- % tissue viability
- Remarks:
- mean corrected percent viability
- Run / experiment:
- 1
- Value:
- 108.6
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- 100%
- Positive controls validity:
- valid
- Remarks:
- 1.2%
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: Not specified
- Direct-MTT reduction: No
- Colour interference with MTT: No
DEMONSTRATION OF TECHNICAL PROFICIENCY: Yes
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Yes
- Acceptance criteria met for positive control: Yes
- Acceptance criteria met for variability between replicate measurements: Yes
- Range of historical values if different from the ones specified in the test guideline: Provided in the study report - Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the experimental conditions of this study, the test item Dimethyl Azelate has to be considered as non-irritant to skin according to CLP regulation (EC) No.1272/2008. It is also not classified according to UN GHS regulation.
- Executive summary:
An in vitro skin irritation study was performed according to the OECD Guideline 439, the EU Method B.46 and in compliance with GLP, using the EPISKINTM reconstructed human epidermis model.
The test item Dimethyl Azelate was applied, as supplied, at the dose of 16 μL to 3 living Reconstructed Human epidermis (SkinEthic RHE® model) during 42 minutes. The application was followed by a rinse with 25 mL of DPBS and a 41 hours post-incubation period at 37°C, 5% CO2. Cell viability was then measured by enzymatic conversion of the vital dye MTT into a blue formazan salt that was quantitatively measured after extraction from tissues.
The mean percent viability of the treated tissues was 108.6%, versus 1.2% in the positive control (5% Sodium Dodecyl Sulfate).
Under the experimental conditions of this study, the test item Dimethyl Azelate has to be considered as Non-irritant to skin to skin according to CLP regulation (EC) No.1272/2008. It is also not classified according to UN GHS regulation.
Reference
Table 7.3.1/1: Mean OD570Values and Percentage Viabilities for the Negative Control Item, Positive Control Item and Test Item
Skin | OD | Mean OD / disc (#) | Mean OD / product | Viability % | Mean viability % | SD | Conclusion | |
Negative control | 1 | 0.750 0.851 0.872 |
0.824 | 0.787 | 104.7 | 100.0 | 5.2 | |
2 | 0.770 0.795 0.813 |
0.793 | 100.8 | |||||
3 | 0.759 0.745 0.726 |
0.743 | 94.4 | |||||
Positive control | 4 | 0.008 0.009 0.010 |
0.009 | 0.009 | 1.1 | 1.2 | 0.2 | Irritant |
5 | 0.008 0.009 0.008 |
0.008 | 1.0 | |||||
6 | 0.010 0.010 0.013 |
0.011 | 1.4 | |||||
Test item | 22 | 0.764 0.827 0.834 |
0.808 | 0.854 | 102.7 | 108.6 | 6.6 | Non irritant |
23 | 0.927 0.896 0.907 |
0.910 | 115.7 | |||||
24 | 0.853 0.855 0.823 |
0.844 | 107.3 |
#: mean of 3 values (triplicate of the same extract)
OD: optical density
The optical density was measured after a 1:2 dilution of the formazan extracts in isopropanol.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 15 Sepember 2017 - 08 December 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- GLP study conducted according to OECD test Guideline No. 492 without any deviation.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- Adopted 28 July 2015
- Deviations:
- no
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- French GLP Compliance Programme for chemical products (inspected on 30-31 January 2017 / signed on 27 April 2017)
- Species:
- other: Reconstructed human cornea-like epithelium tissues (EpiOcular™ tissue model)
- Strain:
- other: Not applicable
- Details on test animals or tissues and environmental conditions:
- - Justification of the test method and considerations regarding applicability: The EpiOcular™ Eye Irritation Test (EIT) was validated by the European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) and Cosmetics Europe between 2008 and 2013. This test guideline is applicable to liquids and semi-solids, so is considered to be applicable to the test item.
CELL SYSTEM:
- EpiOcular™ OCL-212-ver2.0, supplied by MatTek Corporation (Bratislava, Slovakia).
- Lot No.: 27006
- Keratinocyte strain: 4F1188
- Analysis for potential biological contaminants: none detected (HIV-1, Hep. B and Hep. C virus; Bacteria, yeast and other fungi)
- Tissue viability: 1.534, within the acceptance criteria (1.1-3.0)
- Barrier function: 17.77 min, within the acceptance criteria (12.2-37.5)
- Sterility: Sterile
- Transport: Not specified
- Storage: Not specified - Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 50 µL
- Concentration (if solution): not applicable
VEHICLE: Not applicable - Duration of treatment / exposure:
- 30 minutes
- Observation period (in vivo):
- Not applicable
- Duration of post- treatment incubation (in vitro):
- - 12-minute immersion period at room temperature
- 2 hour and 12 minutes post-exposure incubation at 37°C, 5% CO2 - Number of animals or in vitro replicates:
- 2 replicates
- Details on study design:
- - Details of the test procedure used
: procedure for liquids
* Pre-treatment: after an overnight incubation, tissues were pre-wetted with 20 µL of Ca2+Mg2+Free-DPBS. Then tissues were incubated for 30 minutes at standard culture conditions.
* Treatment: 50 µL of test item, positive or negative control was applied to the entire surface of 2 living RhCE tissue replicates during 30 minutes at standard culture conditions.
* Post-exposure incubation period: after treatment, tissues were carefully washed by extensive rinsing with Ca2+Mg2+Free-DPBS. Rinsed tissues were checked for any coloration and for comparable colour with negative control treated tissues (whitish). The rinsing step was followed by a 12-minute immersion period at room temperature in 5 mL of fresh medium to remove any test item absorbed into the tissue. Then the RhCE constructs were incubated for 2 hours and 12 minutes post-exposure incubation at standard culture conditions in 1 mL of fresh medium at 37°C, 5% CO2.
- Doses of test chemical and control substances used : 50 µL
- Duration and temperature of pre-treatment (30 minutes), exposure (30 minutes), post-exposure immersion (12 minutes) and post-exposure incubation (2 hour and 12 minutes)
- Description of any modifications to the test procedure : None
- Indication of controls used for direct MTT-reducers and/or colouring test chemicals (if applicable) : Since the test item did not interact with MTT, none killed control tissue models were added to the study. The test item did not show any coloration potential in presence of water or isopropanol, thus no non-specific coloration control was added to the study.
- Number of tissue replicates used per test chemical and controls (positive control, negative control): 2
- Description of evaluation criteria used including the justification for the selection of the cut-off point for the prediction model :
If the test item-treated tissue viability is > 60% relative to the negative control treated tissue viability, the test item is labeled non-irritant.
If the test item-treated tissue viability is ≤ 60% relative to negative control treated tissue viability, the test item is identified potentially requiring classification and labelling according to UN GHS (Category 2 or Category 1).
According to OECD guideline 492 a single test composed of at least two tissue replicates should be sufficient for a test chemical, when the result is unequivocal. However, in cases of borderline results, such as non-concordant replicate measurements and/or mean percent tissue viability equal to 60±5%, a second test should be considered, as well as a third one in case of discordant results between the first two tests.
- Reference to historical positive and negative control results demonstrating suitable run acceptance criteria : Yes, attached to the study report.
* Historical negative control ranges 83.17 - 116.83%
* Historical positive control ranges 6.50 - 45.11%
- Complete supporting information for the specific RhCE tissue construct used : Yes, attached to the study report.
- Reference to historical data of the RhCE tissue construct : No
- Demonstration of proficiency in performing the test method before routine use by testing of the proficiency chemicals : Yes, attached to the study report.
- Positive and negative control means and acceptance ranges based on historical data : Yes
- Acceptable variability between tissue replicates for positive and negative controls: Yes
- Acceptable variability between tissue replicates for the test chemical: Yes - Irritation parameter:
- other: % Tissue viability
- Remarks:
- mean corrected percent viability
- Run / experiment:
- 1
- Value:
- 92.81
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- 100.00%
- Positive controls validity:
- valid
- Remarks:
- 43.31%
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: Not specified
DEMONSTRATION OF TECHNICAL PROFICIENCY: Yes
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Yes, OD values included between 0.848 and 1.169
- Acceptance criteria met for positive control: % viability= 43.31%
- Range of historical values if different from the ones specified in the test guideline:
- Negative control: OD values [0.645-1.563]
- Positive control: % viability [6.50-45.11] - Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the experimental conditions adopted and in accordance with Regulation EC No. 1272/2008, test item, Dimethyl Azelate, does not require classification for eye irritation or serious eye damage according to CLP and UN-GHS regulations.
- Executive summary:
A study was performed to assess the eye irritation potential of the test item by means of the Human Cornea Model Test. The study was conducted according to the OECD guideline No. 492 and in compliance with GLP.
The test item, Dimethyl Azelate, was applied as supplied at the dose of 50 µL to 2 living DPBS pre-treated RhCE (EpiOcularTM tissue model) during 30 minutes at 37°C, 5% CO2, 95% humidity (standard culture conditions). The exposure period was followed by extensive rinsing with DPBS at room temperature, a 12 minutes post-exposure immersion period at room temperature and a 2 hours and 12 minutes post-exposure incubation at standard culture conditions. The tissue viability was measured by performing an MTT assay.
The mean percent tissue viability of the RhCE replicates treated with the test item Dimethyl Azelate was 92.81 %, versus 43.31% in the positive control (Methyl acetate).
Under the experimental conditions adopted and in accordance with Regulation EC No. 1272/2008, test item Dimethyl Azelate does not require classification for eye irritation or serious eye damage according to CLP and UN-GHS regulations.
Reference
Table 7.3.2/1: Mean OD570Values and Percentage Viabilities for the Negative Control Item, Positive Control Item and Test Item
Tissue | OD | Mean OD / disc (#) |
Mean OD / product |
Viability % |
Mean viability % |
Difference of viability % |
Conclusion | |
Negative control | 1 | 0.849 0.848 0.856 |
0.851 | 1.002 | 84.93 | 100.00 | 30.14 | |
2 | 1.169 1.135 1.157 |
1.153 | 115.07 | |||||
Positive control | 3 | 0.405 0.399 0.399 |
0.401 | 0.434 | 40.02 | 43.31 | 6.59 | UN GHS Category 2 or 1 |
4 | 0.467 0.463 0.471 |
0.467 | 46.61 | |||||
Test item | 5 | 0.970 0.902 0.914 |
0.932 | 0.930 | 93.01 | 92.81 | 0.40 | No Category |
6 | 0.929 0.928 0.925 |
0.928 | 92.61 |
Note: the optical density was measured after a 1:2 dilution of the formazan extracts in isopropanol.
#: mean of 3 values (triplicate of the same extract)
OD: optical density
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Skin irritation/corrosion:
One key study was identified for the skin irritation. A key study (Floriot, 2017, Rel.1) was performed to evaluate the skin irritation potential of the test substance, Dimethyl Azelate. This in vitro skin irritation study was performed according to the OECD Guideline 439 and in compliance with GLP, using the SkinEthic Reconstructed Human Epidermis® model.
The test item Dimethyl Azelate was applied, as supplied, at the dose of 16 μL to 3 living Reconstructed Human epidermis (SkinEthic RHE® model) during 42 minutes. The application was followed by a rinse with 25 mL of DPBS and a 41 hours post-incubation period at 37°C, 5% CO2. Cell viability was then measured by enzymatic conversion of the vital dye MTT into a blue formazan salt that was quantitatively measured after extraction from tissues. The mean percent viability of the treated tissues was 108.6%, versus 1.2% in the positive control (5% Sodium Dodecyl Sulfate).
Under the experimental conditions of this study, the test item Dimethyl Azelate has to be considered as Non-irritant to skin to skin according to CLP regulation (EC) No.1272/2008. It is also not classified according to UN GHS regulation.
Eye irritation:
A key study was identified for eye irritation. This in vitro eye irritation test (Floriot, 2017, Rel.1) was performed according to the OECD Guideline 492 and in compliance with GLP, using the Reconstructed human Cornea-like Epithelium (RhCE).
The test item, Dimethyl Azelate,was applied as supplied at the dose of 50 µL to 2 living DPBS pre-treated RhCE (EpiOcularTMtissue model) during 30 minutes at 37°C, 5% CO2, 95% humidity (standard culture conditions). The exposure period was followed by extensive rinsing with DPBS at room temperature, a 12 minutes post-exposure immersion period at room temperature and a 2 hours and 12 minutes post-exposure incubation at standard culture conditions. The tissue viability was measured by performing an MTT assay. The mean percent tissue viability of the RhCE replicates treated with the test item Dimethyl Azelatewas 92.81 %, versus 43.31% in the positive control (Methyl acetate).
Under the experimental conditions adopted and in accordance with Regulation EC No. 1272/2008, test item Dimethyl Azelate does not require classification for eye irritation or serious eye damage according to CLP and UN-GHS regulations.
Respiratory irritation:
No data was available regarding respiratory irritation assessment.
Justification for classification or non-classification
Harmonized classification:
Dimethyl Azelate does not have harmonized classification according to the Regulation (EC) No. 1272/2008.
Self-classification:
Based on the available information, the substance should not be classified as skin irritant according to the Annex VI of the Regulation (EC) No. 1272/2008 (CLP) and to the UN-GHS.
Based on the available information, the substance should not be classified as eye irritant according to the Annex VI of the Regulation (EC) No. 1272/2008 (CLP) and to the UN-GHS.
No data was available regarding respiratory irritation. However, the substance not being skin or eye irritant, no classification is expected for respiratory irritation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.